Salt Lake City-based Intermountain Healthcare will allot a total of $200,000 in Genomic Innovation Grants, benefiting biomedical research projects aiming to accelerate precision medicine treatments.
The grants seek to both foster scientific collaboration and further the work of Intermountain's Precision Genomics program, which conducts research using techniques such as next-generation sequencing, bioinformatic analysis and more.
"Translational research plays an important role in Intermountain Healthcare's mission to help people live the healthiest lives possible," David Jones, PhD, senior scientific program director for Intermountain Precision Genomics, said in a statement. "Genomic Innovation Grants combine our translational research services with innovative research ideas to champion new discovery and further precision medicine and its clinical application."
More articles on innovation:
To innovate in an ordinary but meaningful way: Pick up the phone
Organizations led by 'inventor CEOs' produce higher-quality innovation: report
4 ways innovation hubs drive digital transformation